Lindbrook Capital, LLC Dexcom Inc Transaction History

Lindbrook Capital, LLC

$1.09 Billion
Q4 2024

A detailed history of Lindbrook Capital, LLC transactions in Dexcom Inc stock. As of the latest transaction made, Lindbrook Capital, LLC holds 1,740 shares of DXCM stock, worth $153,763. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,740

Previous 501 247.31%

Holding current value

$153,763

Previous $33,000 309.09%

% of portfolio

0.01%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 06, 2025	BUY	$65.68 - $81.01 $81,377 - $100,371	1,239 Added 247.31%	1,740 $135,000
Q3 2024 Nov 01, 2024	SELL	$64.0 - $116.06 $77,632 - $140,780	-1,213 Reduced 70.77%	501 $33,000
Q2 2024 Jul 31, 2024	SELL	$110.31 - $140.45 $4,522 - $5,758	-41 Reduced 2.34%	1,714 $194,000
Q1 2024 Apr 25, 2024	BUY	$114.22 - $140.1 $19,645 - $24,097	172 Added 10.87%	1,755 $243,000
Q4 2023 Jan 31, 2024	BUY	$75.49 - $124.16 $20,231 - $33,274	268 Added 20.38%	1,583 $196,000
Q3 2023 Oct 25, 2023	SELL	$86.06 - $137.93 $22,719 - $36,413	-264 Reduced 16.72%	1,315 $122,000
Q2 2023 Jul 28, 2023	BUY	$112.47 - $130.98 $112 - $130	1 Added 0.06%	1,579 $202,000
Q1 2023 Apr 26, 2023	BUY	$104.0 - $122.92 $11,128 - $13,152	107 Added 7.27%	1,578 $183,000
Q4 2022 Jan 24, 2023	BUY	$84.98 - $122.67 $35,861 - $51,766	422 Added 40.23%	1,471 $0
Q3 2022 Nov 10, 2022	BUY	$76.35 - $94.18 $22,523 - $27,783	295 Added 39.12%	1,049 $84,000
Q2 2022 Aug 01, 2022	BUY	$67.99 - $132.89 $39,094 - $76,411	575 Added 321.23%	754 $56,000
Q1 2022 Apr 21, 2022	SELL	$94.08 - $130.2 $658 - $911	-7 Reduced 3.76%	179 $92,000
Q4 2021 Jan 18, 2022	BUY	$129.87 - $162.82 $8,181 - $10,257	63 Added 51.22%	186 $100,000
Q3 2021 Nov 05, 2021	BUY	$106.71 - $143.18 $746 - $1,002	7 Added 6.03%	123 $67,000
Q2 2021 Jul 27, 2021	SELL	$80.99 - $107.93 $890 - $1,187	-11 Reduced 8.66%	116 $50,000
Q1 2021 Apr 28, 2021	BUY	$84.79 - $104.74 $1,441 - $1,780	17 Added 15.45%	127 $46,000
Q4 2020 Jan 27, 2021	SELL	$78.0 - $104.5 $2,652 - $3,553	-34 Reduced 23.61%	110 $41,000
Q3 2020 Nov 03, 2020	BUY	$95.51 - $112.95 $2,674 - $3,162	28 Added 24.14%	144 $59,000
Q2 2020 Jul 27, 2020	SELL	$62.68 - $105.34 $1,128 - $1,896	-18 Reduced 13.43%	116 $47,000
Q1 2020 Apr 22, 2020	BUY	$47.79 - $75.63 $1,911 - $3,025	40 Added 42.55%	134 $36,000
Q4 2019 Jan 27, 2020	BUY	$36.62 - $57.29 $695 - $1,088	19 Added 25.33%	94 $21,000
Q2 2019 Jul 24, 2019	SELL	$27.84 - $38.92 $278 - $389	-10 Reduced 11.76%	75 $11,000
Q1 2019 Apr 23, 2019	BUY	$28.07 - $38.18 $280 - $381	10 Added 13.33%	85 $10,000
Q4 2018 Feb 07, 2019	BUY	$26.99 - $37.37 $2,024 - $2,802	75 New	75 $8,000

Others Institutions Holding DXCM

# of Institutions

1,085

Shares Held

352M

Call Options Held

8.45M

Put Options Held

5.75M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $34.1B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lindbrook Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lindbrook Capital, LLC with notifications on news.

Account

Lindbrook Capital, LLC Dexcom Inc Transaction History